Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery and Evaluation of 6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline Derivatives as P-gp Inhibitors to Overcome Multidrug Resistance in Eca109/VCR Cells.

ChemMedChem·2026
Same author

4-Dimethylaminophenol: A 'Smaller'-Molecule PPI Inhibitor Targeting the PSD95 GK Domain Against Ischemic Stroke.

Angewandte Chemie (International ed. in English)·2026
Same author

Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier Integrity.

Circulation·2026
Same author

Anchoring Co Porphyrins in N-Doped 3D Graphene/CNTs to Synergize Macrocyclic and Electronic Configurations for Boosted Electrocatalytic Oxygen Reduction.

The journal of physical chemistry letters·2026
Same author

Serotonin receptor type 7 (5-HT7) promotes colorectal cancer progression by activating Wnt/β-catenin signaling via interacting with CK1ε.

Oncogene·2025
Same author

Palladium-catalysed asymmetric annulations of Morita-Baylis-Hillman carbonates with allenes or alkenes <i>via</i> migratory insertion.

Chemical science·2025

Related Experiment Video

Updated: May 15, 2025

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
09:36

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures

Published on: March 10, 2021

2.7K

Neuroprotective and Anti-inflammatory Dual-Phenotypic Drug Screening Strategies.

Xue-Hui Liu1, Hong-Yuan Liu1, Jing Gu1

  • 1Department of Medicinal Chemistry, Third Military Medical University, Chongqing 400038, China.

ACS Chemical Neuroscience
|April 10, 2025
PubMed
Summary

A new dual-phenotypic drug screening approach targets both neuronal protection and anti-inflammation for ischemia-reperfusion injury. This system biology method improves therapeutic development for complex conditions.

Keywords:
anti-inflammatorydual-phenotypic drug screening strategyischemia-reperfusion injuryischemic strokeneuronal protection

More Related Videos

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.1K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.4K

Related Experiment Videos

Last Updated: May 15, 2025

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
09:36

High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures

Published on: March 10, 2021

2.7K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.1K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

17.4K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biomedical Engineering

Background:

  • Ischemia-reperfusion injury is a complex, multifactorial condition.
  • Traditional single-target drug development often yields suboptimal therapeutic outcomes for such conditions.

Purpose of the Study:

  • To introduce a novel dual-phenotypic drug screening strategy.
  • To target both neuronal protective and anti-inflammatory effects for treating ischemia-reperfusion injury.

Main Methods:

  • Utilized primary neurons with oxygen-glucose deprivation/reoxygenation (OGD/R) and lipopolysaccharide (LPS)-activated microglial models.
  • Employed coculture systems and brain organoids for in vitro evaluation.
  • Conducted in vivo evaluation using mouse middle cerebral artery occlusion/reperfusion (MCAO/R) models.

Main Results:

  • The dual-phenotypic strategy integrates neuronal and inflammatory pathways.
  • Demonstrated a shift from single-factorial to system biology-based approaches.
  • Showcased potential for enhanced therapeutic development.

Conclusions:

  • The dual-phenotypic drug screening strategy represents a paradigm shift in treating complex diseases.
  • This integrated methodology offers significant advantages for developing effective therapies for ischemia-reperfusion injury.